Health Care & Life Sciences » Pharmaceuticals | Pieris Pharmaceuticals Inc.

Pieris Pharmaceuticals Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
66.20
9,850.00
14,058.60
22,799.20
17,647.00
26,754
Depreciation, Depletion & Amortization
384.70
367.00
307.90
361.40
369.00
570
Other Funds
414.30
3,824.50
1,836.00
1,954.70
3,495.00
3,389
Funds from Operations
865.10
5,658.50
11,914.70
20,483.10
13,783.00
22,959
Changes in Working Capital
4,055.90
522.80
790.80
6,095.20
63,537.00
21,893
Net Operating Cash Flow
3,190.70
5,135.70
12,705.50
14,387.90
49,754.00
1,066
Capital Expenditures
49.50
267.40
620.70
580.60
1,950.00
Sale of Fixed Assets & Businesses
-
-
-
21.00
-
Purchase/Sale of Investments
-
-
-
-
43,925.00
Net Investing Cash Flow
49.50
267.40
620.70
559.70
45,875.00
Issuance/Reduction of Debt, Net
327.20
1,028.60
1,157.90
-
-
Net Financing Cash Flow
327.20
20,333.80
24,616.00
15,221.00
4,090.00
Net Change in Cash
2,752.00
14,714.80
10,874.90
6.40
8,522.00
Free Cash Flow
3,240.20
5,403.10
13,326.20
14,968.60
47,804.00
Change in Capital Stock
-
19,305.30
25,774.00
15,221.00
4,090.00
Exchange Rate Effect
161.00
215.90
414.90
267.00
553.00

About Pieris Pharmaceuticals

View Profile
Address
255 State Street
Boston Massachusetts 02109
United States
Employees -
Website http://www.pieris.com
Updated 07/08/2019
Pieris Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which engages in the discovery and development of Anticalin class of biotherapeutics. It offers technology to create differentiated drugs that can help patients suffering from cancer, severe asthma, anemia, and other medical conditions with an unmet medical need. The company was founded by Claus Schalper and Arne Skerra in 2001 and is headquartered in Boston, MA.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.